COLDASTOP NASEN-ÖL ninatilgad, lahus 에스토니아 - 에스토니아어 - Ravimiamet

coldastop nasen-öl ninatilgad, lahus

desitin arzneimittel gmbh - retinool+tokoferool - ninatilgad, lahus - 15000rÜ+20mg 1ml 20ml 1tk

PINOSOL ninatilgad, lahus 에스토니아 - 에스토니아어 - Ravimiamet

pinosol ninatilgad, lahus

zentiva a.s. - tokoferool+eukalüptiõli+männi eeterlik õli+tümool+piparmündiõli+guaiasuleen - ninatilgad, lahus - 17mg+5mg+37,52mg+0,32mg+10mg+0,2mg 1g 10ml 1tk

OXYTOCIN-GRINDEKS süste-/infusioonilahus 에스토니아 - 에스토니아어 - Ravimiamet

oxytocin-grindeks süste-/infusioonilahus

grindeks as - oksütotsiin - süste-/infusioonilahus - 5rÜ 1ml 1ml 10tk

EDESIA kaetud tablett 에스토니아 - 에스토니아어 - Ravimiamet

edesia kaetud tablett

gedeon richter plc. - gestodeen+etünüülöstradiool - kaetud tablett - 75mcg+20mcg 21tk; 75mcg+20mcg 126tk

Oxyto-kel süstelahus 에스토니아 - 에스토니아어 - Ravimiamet

oxyto-kel süstelahus

kela - kempisch laboratorium - kela laboratoria - oksütotsiin - süstelahus - 10rÜ 1ml 30ml 1tk

FLEREE intrauteriinne ravivahend 에스토니아 - 에스토니아어 - Ravimiamet

fleree intrauteriinne ravivahend

bayer ag - levonorgestreel - intrauteriinne ravivahend - 13,5mg 5tk

MINULET kaetud tablett 에스토니아 - 에스토니아어 - Ravimiamet

minulet kaetud tablett

pfizer europe ma eeig - gestodeen+etünüülöstradiool - kaetud tablett - 75mcg+30mcg 63tk

LINDYNETTE 20 kaetud tablett 에스토니아 - 에스토니아어 - Ravimiamet

lindynette 20 kaetud tablett

gedeon richter plc. - gestodeen+etünüülöstradiool - kaetud tablett - 0,075mg+0,02mg 63tk

LINDYNETTE 30 kaetud tablett 에스토니아 - 에스토니아어 - Ravimiamet

lindynette 30 kaetud tablett

gedeon richter plc. - gestodeen+etünüülöstradiool - kaetud tablett - 0,075mg+0,03mg 63tk

Veklury 유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.